Previous studies have shown that the expression and/or activity of ARF family proteins and their GEFs, GAPs, and effectors are frequently upregulated in several types of cancer and play a role in cancer cell migration, invasion, and proliferation[10, 13, 14]. Here, CDKN2A is linked to cancer.